Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
View Patent ↗An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying the best treatment or agent for the particular patient. Specific method innovations such as tissue sample preparation techniques render this method practically as well as theoretically useful. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample, rather than enzymatically dissociated cell suspensions or preparations, for initial tissue culture monolayer preparation. With respect to the culturing of malignant cells, for example, it is believed (without any intention of being bound by the theory) that by maintaining the malignant cells within a multicellular particulate of the originating tissue, growth of the malignant cells themselves is facilitated versus the overgrowth of fibroblasts or other cells which tends to occur when suspended tumor cells are grown in culture. Practical monolayers of cells may thus be formed to enable meaningful screening of a plurality of treatments and/or agents. Growth of cells is monitored to ascertain the time to initiate the assay and to determine the growth rate of the cultured cells; sequence and timing of drug addition is also monitored and optimized. By subjecting uniform samples of cells to a wide variety of active agents (and concentrations thereof), the most promising agent and concentration for treatment of a particular patient can be determined. For assays concerning cancer treatment, a two-stage evaluation is contemplated in which both acute cytotoxic and longer term inhibitory effect of a given anti-cancer agent are investigated.
1. A chemosensitivity assay comprising the steps of:
exposing a multicellular tissue explant to growth medium that is free of enzymes which digest said explant, such that said explant produces a cell culture monolayer;
preparing a cell suspension from said cell culture monolayer;
inoculating cells from said cell suspension into at least one segregated site;
exposing said segregated site to at least one chemical agent; and
assessing the chemosensitivity of said cells in said segregated site.
2. The assay of claim 1 , wherein said explant comprises tumor tissue.
3. The assay of claim 1 , further comprising the step of mechanically fragmenting the multicellular tissue explant in a medium that is free of enzymes that digest said explant.
4. The assay of claim 1 , wherein said cell culture monolayer substantially comprises tumor cells.
5. A chemosensitivity assay, comprising the steps of:
exposing a multicellular tissue explant to growth medium that is free of enzymes which digest said explant, such that said explant, such that said explant produces a cell culture monolayer;
preparing a cell suspension from said monolayer;
exposing cells of said cell suspension to at least one chemical agent; and
assessing the chemosensitivity of said cells to said agent.
6. The assay of claim 5 , further comprising the step of inoculating cells from said suspension into at least one segregated site.
7. The assay of claim 5 , wherein said explant comprises tumor tissue.
8. The assay of claim 5 , further comprising the step of mechanically fragmenting the multicellular tissue explant in a medium that is free of enzymes that digest said explant.
9. The assay of claim 7 , wherein said cell culture monolayer substantially comprises tumor cells.
10. A chemosensitivity assay, comprising the steps of:
preparing a cell suspension from a cell culture monolayer comprising a predominant population of cells of interest;
exposing cells of said suspension to at least one chemical agent; and
assessing the chemosensitivity of said cells to said agent.
11. The assay of claim 10 , further comprising the step of inoculating cells from said suspension into at least one segregated site.
12. The assay of claim 10 , wherein said cell culture monolayer is obtained from an explant which comprises tumor tissue.
13. The assay of claim 10 , further comprising the step of mechanically fragmenting a multicellular tissue explant in a medium that is free of enzymes which digest said explant.
14. The assay of claim 12 , wherein said cell culture monolayer substantially comprises tumor cells.